Von Hippel-Lindau (VHL) disease is a rare, autosomal dominant genetic condition that causes tumors and cysts to form in multiple organs — most often the brain, spinal cord, retina, kidneys, pancreas, and adrenal glands. Because the mutation is inherited, carriers typically begin lifelong tumor surveillance in childhood or early adulthood, watching for growths that can appear at any time, in almost any organ, for the rest of their lives. That open-ended uncertainty might suggest anxiety is the main burden — but new research suggests something more specific: for most patients, it is not the diagnosis itself but the repeated surgeries it leads to that take the clearest toll on mental health.
How Common Is the Impact?
A 2025 international survey of 220 people with VHL disease, conducted through the VHL Alliance patient organization across the United States, Canada, the United Kingdom, France, and Germany, found just how central surgery is to the disease experience. Respondents had a median age of 40 and had lived with the diagnosis for a median of 15.8 years. Fully 93.2% had undergone at least one VHL-related surgery, and 77.7% had undergone multiple surgeries — a median of 4.0 operations per person. Among those who described their most recent surgery, 51.2% said it had worsened their mental health, 51.8% said it had worsened their fatigue, and 45.2% said it had worsened their ability to manage daily life. When asked what they wanted most from future treatment, 47.3% ranked having fewer surgeries as their top goal, and 73% said they would prefer a medication that could delay surgery over continuing with the current surgical approach.
The Daily Challenges
- Unpredictable timing. Because tumors can appear or grow between scans, a stable period of life can end with a single surveillance result, often with little warning and no way to plan around it.
- Repeated recovery cycles. Unlike a one-time risk-reducing surgery, VHL often means going through physical and emotional recovery again and again, with no clear point at which treatment is simply finished.
- Multi-organ vigilance. Tracking symptoms across the brain, spine, eyes, kidneys, pancreas, and adrenal glands at once is its own ongoing cognitive and emotional workload.
- Career and financial strain. Repeated time off work for surgery and recovery, combined with the possibility of future procedures, can make it difficult to plan a career or budget with confidence.
- Family communication. Because VHL is inherited, each child of a carrier has a 50% chance of inheriting the mutation, and deciding when and how to talk with children about this can weigh heavily on parents.
When Surveillance Itself Takes a Toll
A 2026 systematic review of 36 studies on psychosocial outcomes across hereditary endocrine tumor syndromes — including VHL, multiple endocrine neoplasia, and SDHx-related conditions — found that the regular scans and bloodwork meant to catch tumors early have an ambivalent emotional effect. For many patients, surveillance appointments provide a sense of control over an otherwise unpredictable disease, yet these same appointments also function as a recurring, unavoidable reminder that the condition is still there. For VHL specifically, the review found that patients and family members described a wide range of experiences with surveillance, reflecting how differently the disease's course can unfold from person to person.
The Psychological Weight of Powerlessness
A 2026 qualitative study interviewed 12 people with VHL-associated tumors in the brain or spinal cord and identified four recurring psychological themes. The first, powerlessness, captured the frustration of living with a disease whose progression cannot be predicted or controlled. The second, negative emotional experiences, included guilt and self-blame, lowered self-esteem, and depression, sometimes tied to the possibility of passing the condition to children. The third, compromise, described how many patients eventually arrived at an acceptance of their situation alongside genuine hope. The fourth, persistent worry, centered on family, employment and finances, and an uncertain future. Together, these themes help explain why the surgery-focused findings above cut so deep: each new operation is not an isolated medical event but another encounter with the very unpredictability that patients describe as the hardest part of living with VHL.
Practical Steps
- Seek care at a specialized VHL clinic. Multidisciplinary centers familiar with VHL can coordinate surveillance across organs and reduce the number of separate appointments and unknowns patients have to manage alone.
- Connect with others who have VHL. Patient organizations such as the VHL Alliance offer community support from people who understand the specific experience of repeated surgery and lifelong surveillance.
- Ask about mental health screening at surveillance visits. Raising mental health directly with your care team, rather than waiting to be asked, can help catch and address distress before it becomes severe.
- Build in recovery time around known surveillance points. Planning rest and support ahead of scheduled scans or likely surgery windows can soften the disruption when a new procedure becomes necessary.
- Consider therapy focused on uncertainty, not just surgery. Because much of the distress in VHL comes from not knowing what the next scan will show, approaches that build tolerance for uncertainty can help as much as support around any single operation.